BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 19553400)

  • 1. A case of mucin-producing cholangiocarcinoma.
    Matsuba H; Sakamoto Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):467. PubMed ID: 19553400
    [No Abstract]   [Full Text] [Related]  

  • 2. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal mucosal-spreading mucin-producing peripheral cholangiocarcinoma of the liver.
    Lim JH; Kim YI; Park CK
    Abdom Imaging; 2000; 25(1):89-92. PubMed ID: 10652930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of alpha-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence.
    Vij K; Wang HL
    Int J Surg Pathol; 2008 Apr; 16(2):194-8. PubMed ID: 18417680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma.
    Liu YF; Zhao R; Guo S; Wang XQ; Lian PL; Chen YG; Xu KS
    Ann Surg Oncol; 2011 Mar; 18(3):872-9. PubMed ID: 20848225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
    Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
    Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
    Hunt JP; Varnholt H
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
    [No Abstract]   [Full Text] [Related]  

  • 8. Mucin-producing intrahepatic cholangiocarcinoma with portal vein thrombosis.
    Nakagohri T; Kinoshita T; Konishi M; Inoue K; Takahashi S; Tanizawa Y; Kobayashi A
    Hepatogastroenterology; 2003; 50(54):2194-5. PubMed ID: 14696496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical treatment for intrahepatic cholangiocarcinoma].
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():469-75. PubMed ID: 16457307
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic cholangiocarcinoma: a worthy challenge.
    Bartlett DL
    Cancer J; 2009; 15(3):255-6. PubMed ID: 19556913
    [No Abstract]   [Full Text] [Related]  

  • 12. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.
    Aishima S; Taguchi K; Terashi T; Matsuura S; Shimada M; Tsuneyoshi M
    Mod Pathol; 2003 Oct; 16(10):1019-27. PubMed ID: 14559985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma.
    Okabe H; Beppu T; Hayashi H; Horino K; Masuda T; Komori H; Ishikawa S; Watanabe M; Takamori H; Iyama K; Baba H
    Ann Surg Oncol; 2009 Sep; 16(9):2555-64. PubMed ID: 19548033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrahepatic cholangiocarcinoma: current surgical strategy.
    Boutros C; Somasundar P; Espat NJ
    Surg Oncol Clin N Am; 2009 Apr; 18(2):269-88, viii. PubMed ID: 19306812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regarding: epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma.
    Balsano C; Conti B; Arciello M
    Ann Surg Oncol; 2011 Mar; 18(3):896; author reply 897. PubMed ID: 20645009
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraductal growth-type mucin-producing peripheral cholangiocarcinoma associated with biliary papillomatosis.
    Güllüoglu MG; Ozden I; Poyanli A; Cevikbas U; Ariogul O
    Ann Diagn Pathol; 2007 Feb; 11(1):34-8. PubMed ID: 17240305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.
    Uenishi T; Kubo S; Yamazaki O; Yamada T; Sasaki Y; Nagano H; Monden M
    J Hepatobiliary Pancreat Surg; 2008; 15(4):417-22. PubMed ID: 18670844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Place of surgery in opisthorchiasis associated cholangiocarcinoma.
    Bhudhisawasdi V
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 1():85-90. PubMed ID: 9656356
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cholangiocarcinomas developing on multiple bile duct hamartomas syndrome].
    Droy L; Sagan C; Paineau J; Gournay J; Mosnier JF
    Ann Pathol; 2009 Feb; 29(1):24-7. PubMed ID: 19233090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.